athenahealth shares downgraded to ‘hold’ rating: 4 quick facts

Zacks Investment Research downgraded shares of athenahealth from a buy rating to a hold rating, according to MarketBeat, which cites a research note published April 22.

Advertisement

Here are four quick facts.

1. Zacks said athenahealth’s fourth-quarter 2015 earnings were impressive, driven by healthy growth across athenahealth-branded services as well as physician additions at all three software suites, according to Mas Market News. “We believe that athenahealth’s strong product portfolio, expanding physician base and unique business model will continue to drive the top line,” Zacks added.

2. However, athenahealth has challenges, including lack of enterprise-sized deals, winding up of government funded stimulus and increasing competition in the health IT market, Zacks said, according to Mas Market News.

3. Shares of athenahealth opened at $138.64 Monday.

4. athenahealth has a 12-month low of $110.68 and a 12-month high of $170.42.

 

More articles on finance and revenue cycle management:

Elliot Hospital’s pediatric ICU to close: 3 things to know
Arkansas governor provides lifeline for state’s hybrid Medicaid expansion
News outlets launch reporting project to bring clarity to healthcare costs in Florida

 

 

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Download Whitepaper

The cost-saving opportunity most health systems overlook

Many hospitals and health systems scrutinize staffing, service lines, and payer contracts for savings. Fewer look at one of their largest assets: real estate.…

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.